Here, we designed and prepared cRGD modified cationic liposomes (cRGD-CL) for the delivery of OC-2 shRNA (pshOC-2) to investigate the effect of OC-2 interference on breast cancer survival, migration and metastasis. This evidence concerns the gene ONECUT2 and breast carcinoma.